Dressing Selection Framework & Product Categories

Dressing Selection Framework & Product Categories

Clinical Framework for Dressing Selection

In advanced wound management, dressing selection is governed by the principle of maintaining a moist wound healing environment while protecting the periwound skin from maceration and managing tissue bioburden. The internationally recognized TIME framework provides a systematic clinical methodology for assessing wound characteristics and guiding product selection:

• T (Tissue Management): Identification and removal of non-viable, necrotic tissue or slough to expose healthy granulating tissue.
• I (Infection & Inflammation Control): Assessment of clinical infection, systemic inflammatory markers, and local microbial bioburden or biofilm.
• M (Moisture Balance): Regulation of wound exudate to prevent both wound bed desiccation and periwound skin maceration.
• E (Edge of Wound / Epithelialization): Promotion of keratinocyte migration from the wound margins across a healthy, moist, granulating bed.

Exudate management is central to dressing selection. Exudate contains endogenous proteolytic enzymes (such as matrix metalloproteinases, or MMPs), inflammatory cytokines, and cellular waste. In chronic wounds, elevated MMP levels degrade essential growth factors and newly deposited extracellular matrix. Effective dressing selection matches the moisture handling capacity of the product to the exudate output of the wound.

---

Primary vs Secondary Dressings

Understanding the functional distinction between primary and secondary dressings is essential for clinical efficacy and regulatory compliance:

• Primary Dressing: Placed in direct physical contact with the wound bed tissue. Its primary functions include moisture donation, exudate absorption, antimicrobial action, autolytic debridement support, or local hemostasis.
• Secondary Dressing: Applied directly over a primary dressing to secure the primary layer in place, provide additional absorption, cushion the wound from external trauma, or establish an occlusive microbial barrier.

The Moisture Vapor Transmission Rate (MVTR) measures the permeability of a dressing to water vapor and oxygen, expressed in grams per square meter per 24 hours ($g/m^2/24h$). Dressings with low MVTR (e.g., hydrocolloids, transparent films) trap fluid and promote autolysis, whereas dressings with high MVTR (e.g., breathable polyurethane foams) allow excess moisture to evaporate while retaining adequate humidity.

---

Detailed Product Categories & Clinical Indications

1. Hydrogels (Amorphous & Sheet)

• Composition: Water- or glycerin-based polymers containing 80% to 90% water.
• Primary Function: Donates moisture to dry, desiccated wound beds and eschar, facilitating autolytic debridement and soothing painful wounds.
• Exudate Capability: Dry to minimal exudate only.
• Clinical Nuances: Amorphous hydrogels require a secondary cover dressing (e.g., gauze or film). Amorphous gels must be applied carefully within the wound perimeter; over-application onto intact periwound skin causes maceration. Sheet hydrogels offer cooling pain relief for partial-thickness burns and painful radiation dermatitis.

2. Hydrocolloids

• Composition: Elastomeric matrix containing hydrophilic colloidal particles such as sodium carboxymethylcellulose (CMC), gelatin, and pectin, backed by a polyurethane film or foam.
• Primary Function: Absorbs light-to-moderate exudate, forming a moist gel over the wound bed that promotes autolysis and angiogenesis.
• Exudate Capability: Light to moderate exudate.
• Clinical Nuances: As hydrocolloids absorb exudate, the colloidal particles interact with wound fluid to form a characteristic yellowish, foul-smelling gelatinous mass. Clinicians and patients must recognize that this gel residue is a normal chemical byproduct of dressing breakdown and must not be confused with purulent infection. Hydrocolloids are occlusive or semi-occlusive and are strictly contraindicated on infected wounds, third-degree burns, vasculitic ulcers, or heavily exudating wounds.

3. Polyurethane Foams

• Composition: Hydrophilic polyurethane foam with open-cell architecture, often laminated to a semi-permeable film backing.
• Primary Function: High-capacity exudate absorption, thermal insulation, dead-space filling (cavity foam strips), and cushioning protection against friction and shear.
• Exudate Capability: Moderate to heavy exudate.
• Clinical Nuances: Foams do not adhere to moist wound beds but require securement (adhesive border foam vs non-border foam requiring secondary tape or wrap). Highly effective under compression therapy for venous leg ulcers. Contraindicated on dry eschar or minimally exudating wounds as they cause wound bed desiccation.

4. Calcium Alginates & Hydrofibers

• Composition: Alginates are derived from natural brown seaweed (guluronic and mannuronic acid salts). Hydrofibers consist of 100% sodium carboxymethylcellulose fibers.
• Primary Function: Absorption of heavy exudate and gel formation. Alginates undergo an ion-exchange process, swapping calcium ions in the dressing for sodium ions in wound exudate, transforming into a soft hydrophilic gel. The released calcium ions activate platelets, providing local hemostatic properties useful for mild capillary bleeding following debridement. Hydrofibers absorb fluid through vertical wicking, trapping exudate within the fiber structure to prevent lateral migration onto periwound skin.
• Exudate Capability: Moderate to heavy (alginates) to extra-heavy (hydrofibers).
• Clinical Nuances: Both require a secondary dressing. Strictly contraindicated on dry necrotic wounds or minimally exudating wounds; lack of moisture causes fibers to desiccate, adhere to the wound bed, and cause tissue trauma upon removal.

5. Transparent Film Dressings

• Composition: Thin, semi-permeable polyurethane membrane coated with a layer of acrylic adhesive. Permeable to oxygen and water vapor; impermeable to liquids and bacteria.
• Primary Function: Autolytic debridement of clean dry superficial wounds, protection of intact skin against friction (Stage 1 pressure injuries), and securing primary dressings or peripheral IV lines.
• Exudate Capability: None to minimal.
• Clinical Nuances: Allows direct visual monitoring of the wound bed without dressing removal. Strictly contraindicated on infected wounds or moderate-to-heavily exudating wounds, as fluid accumulation under the non-absorbent film causes severe periwound maceration and bacterial proliferation.

6. Topical Antimicrobials: Silver & Cadexomer Iodine

• Composition & Mechanism:
  • Ionic Silver ($Ag^+$): Nanocrystalline or silver salt dressings release free silver ions ($Ag^+$) that disrupt bacterial cell walls, block respiratory enzyme pathways, and denature bacterial DNA/RNA across broad-spectrum Gram-positive, Gram-negative (including MRSA and VRE), and fungal pathogens. Replaced every 1 to 7 days depending on formulation. Recommended for a 2- to 4-week trial period to control bioburden, followed by re-evaluation. Silver nitrate and certain silver formulations can be inactivated by sodium chloride (saline) due to silver chloride precipitation.
  • Cadexomer Iodine: Formulated as 0.9% iodine entrapped within spherical cadexomer starch micro-beads. As the beads absorb exudate, they expand and slowly release non-cytotoxic concentrations (0.9%) of free iodine into the wound bed over 48 to 72 hours. Cadexomer iodine effectively penetrates and degrades bacterial biofilms.
• Cadexomer Iodine Contraindications: Known iodine hypersensitivity, thyroid disorders (Hashimoto's, Graves' disease, toxic nodular goiter), pregnancy, lactation, pediatric patients, and application exceeding 50 grams per single application or 150 grams per week.

7. Contact Layers

• Composition: Single-layer woven or non-woven porous sheets composed of silicone, polyamide, or petroleum-impregnated mesh.
• Primary Function: Acts as an inert protective barrier placed directly over fragile granulation tissue, tendon, bone, or skin grafts. Allows exudate to pass freely through pores into an overlying secondary absorbent dressing while preventing the secondary dressing from adhering to the delicate wound base.

---

Dressing Selection & Category Comparison Matrix

---

TIME Framework Implementation Guide

---

ABWM Exam Scenarios & Clinical Guidelines

Scenario 1: Hydrocolloid Gel Liquefaction vs Purulent Infection

A CWCA clinician removes a hydrocolloid dressing from a Stage 2 sacral pressure injury after 4 days of wear. Underneath the dressing, the clinician observes a thick, yellowish-brown, malodorous gel residue. The periwound skin is soft, non-erythematous, non-tender, and afebrile.

• Clinical Evaluation: The clinician must correctly identify this substance as the expected liquefaction of hydrocolloid particles interacting with exudate.
• Action: Gently cleanse the residue with 0.9% Normal Saline before inspecting the wound bed. Do not misdiagnose as infection or obtain unnecessary wound cultures.

Scenario 2: Heavy Exudate & Periwound Maceration in Venous Ulcers

A patient presents with a full-thickness venous leg ulcer producing copious serosanguinous exudate. The periwound skin exhibits white, waterlogged maceration.

• Clinical Evaluation: The primary goal is vertical absorption to stop horizontal moisture spreading.
• Action: Apply a Hydrofiber or Calcium Alginate primary dressing combined with an absorbent Polyurethane Foam secondary dressing and skin protectant barrier film to the periwound edge. Avoid hydrocolloids or transparent films which would trap fluid and worsen maceration.